Rafferty Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$143K	Sell	11,543 -7,605	-40%	-$102K	﹤0.01%	1040
2025 Q4	$241K	Buy	19,148 +3,705	+24%	+$42.4K	﹤0.01%	1037
2025 Q3	$155K	Sell	15,443 -1,541	-9%	-$13.8K	﹤0.01%	1084
2025 Q2	$137K	Buy	16,984 +3,066	+22%	+$23.1K	﹤0.01%	1063
2025 Q1	$117K	Sell	13,918 -1,745	-11%	-$14.6K	﹤0.01%	1043
2024 Q4	$124K	Sell	15,663 -3,181	-17%	-$26.7K	﹤0.01%	1119
2024 Q3	$157K	Buy	18,844 +1,597	+9%	+$12.5K	﹤0.01%	1118
2024 Q2	$110K	Buy	17,247 +2,106	+14%	+$13.4K	﹤0.01%	1159
2024 Q1	$91.8K	Buy	15,141 +3,348	+28%	+$18.9K	﹤0.01%	1073
2023 Q4	$71.6K	Buy	+11,793	New	+$52.5K	﹤0.01%	1068
2022 Q3	–	Sell	-33,067	Closed	-$105K	–	1148
2022 Q2	$105K	Buy	33,067 +8,344	+34%	+$30.2K	﹤0.01%	1069
2022 Q1	$103K	Sell	24,723 -12,651	-34%	-$56K	﹤0.01%	1170
2021 Q4	$179K	Sell	37,374 -575	-2%	-$2.87K	﹤0.01%	1235
2021 Q3	$203K	Buy	37,949 +23,267	+158%	+$117K	﹤0.01%	1192
2021 Q2	$75K	Buy	+14,682	New	+$83.5K	﹤0.01%	1251
2021 Q1	–	Sell	-17,323	Closed	-$79K	–	1160
2020 Q4	$79K	Buy	17,323 +2,956	+21%	+$13.1K	﹤0.01%	1006
2020 Q3	$56K	Buy	14,367 +2,517	+21%	+$10.8K	﹤0.01%	948
2020 Q2	$56K	Buy	+11,850	New	+$48.8K	﹤0.01%	968